Business · 11/12/2003Updated: 10/17/2026 · 1 min read
FDA Amends Regulations for Electronic Labeling Submission for Human Prescription Drugs and Biologics
Summary
The Food and Drug Administration (FDA) has updated its rules to require the electronic submission of certain labeling content for human prescription drugs and biologics, aiming to streamline the review process and expedite approval of labeling changes.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →